The utility of combinations of drugs directed at specific sites of the same target enzyme — ribonucleotide reductase as the model
- 31 December 1985
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 23, 181-192
- https://doi.org/10.1016/0065-2571(85)90047-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of combinations of deoxyguanosine and 8-aminoguanosine with 2,3-dihydro-1H-imidazo[1,2-b]pyrazole on L1210 cell crowth in cultureBiochemical Pharmacology, 1984
- Synthesis and characterization of N2-(p-n-butylphenyl)-2'-deoxyguanosine and its 5'-triphosphate and their inhibition of HeLa DNA polymerase .alpha.Journal of Medicinal Chemistry, 1984
- Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in cultureAdvances in Enzyme Regulation, 1983
- Salvage capacity of hepatoma 3924A and action of dipyridamoleAdvances in Enzyme Regulation, 1983
- Role of ribonucleotide reductase in cell divisionPharmacology & Therapeutics, 1983
- Regulation of ribonucleotide reductase activity in mammalian cellsMolecular and Cellular Biochemistry, 1983
- Inhibitors of purine nucleoside phosphorylaseBiochemical Pharmacology, 1982
- Synthesis and biological effects of acyclic pyrimidine nucleoside analogsJournal of Medicinal Chemistry, 1981
- Inhibitors of Bacillus subtilis DNA polymerase III. 6-(Arylalkylamino)uracils and 6-anilinouracilsJournal of Medicinal Chemistry, 1977
- Nucleosides of 2-FluoroadenineJournal of Medicinal Chemistry, 1969